Progress along the multi-pronged path towards a cure for HIV was one of the themes at the 20th International AIDS Conference (AIDS 2014), taking place this week in Melbourne. Researchers provided updates on the "Mississippi Baby," a novel assay for detecting low levels of hidden virus in the body, and using the anti-cancer drug romidepsin to reactivate latent virus.
The 20th International AIDS Conference (AIDS 2014) kicked off Sunday in Melbourne, Australia. With the theme of "Stepping Up the Pace" in the response to HIV/AIDS, delegates will focus on expanded access to HIV and hepatitis C treatment, the promise of biomedical prevention, ending criminalization of people with HIV, and reaching key populations including gay men, transgender people, sex workers, prisoners, and people who use drugs.
Two studies presented at the 20thInternational AIDS Conference this week in Melbourne showed that all-oral regimens of direct-acting antiviral agents for hepatitis C are safe and effective for HIV positive people. Both regimens demonstrated sustained virological response rates similar to those seen in people with HCV alone.
More than 100 participants packed the Eureka Valley Recreation Center in San Francisco on May 20 for the latest Real Talk discussion of new HIV prevention strategies including pre-exposure prophylaxis (PrEP) and antiretroviral treatment as prevention.